Title: Radiodermatitis Market share forecast to witness considerable growth from 2017 to 2024
1Radiodermatitis Market Size, Industry Analysis
Report, Regional Outlook, 2017 2024 Global
Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Low Power Wide Area Network
2Brief Detail of Radiodermatitis Market
- Increasing obesity prevalence owing to lack of
physical activity, unhealthy dietary habits
coupled with rising smoking and tobacco usage are
yet another paramount factor propelling the
radiodermatitis market growth. - The larger surface area is exposed to radiation
which damages the skin tissues and blood supply
causing skin abrasions and wounds to the obese
patients. Hence, radiodermatitis products enable
healing of such wounds and tissue damages
propelling business growth in the future. - Increasing number of organizations formed to
enhance public awareness pertaining to proper
management and prevention of radiation dermatitis
will create immense growth opportunities in
future. For instance, the European Oncology
Nursing Society issued guidelines and
recommendations related to the radiation
dermatitis symptoms, risk factors and clinical
measurement tools to advance patient care across
the globe. -
3- Moreover, development of assessment tools by
various organizations such as the Radiation
Therapy Oncology Group (RTOG) and National Cancer
Institute (NCI) used to identify degrees of skin
reactions and to determine the severity of
radiation dermatitis are propelling demand for
topical creams, gels, and dressings. - Growing number of clinical research and
development activities for developing innovative
products used to treat adverse effects of
radiation therapies will further expand product
pipeline over the forecast years. However,
improper usage and adverse side-effects of
radiation dermatitis products can hamper market
growth.
4Regional Analysis of Radiodermatitis Market
- Some of the key industry players are Acelity,
Smith Nephew, Molnlycke Health Care, Derma
Sciences, Stratpharma, ConvaTec, 3M, BMG Pharma
and Laboratorios LETI, Alliqua BioMedical.
Mergers acquisition, partnership agreements and
new product launch are the major strategies
adopted by the industry players to expand their
existing portfolio and gain foothold in the
market. - For instance, in March 2015, Laboratorios LETI,
post partnership with Stratpharma launched range
of products such as Stratamed and StrataXRT for
prevention and treatment of wounds, skin scars
and radiodermatitis in Spain and Portuguese. This
strategic move enables the company to strengthen
its global presence.
5 Browse Full Market Research Report On
Radiodermatitis Market _at_ http//bit.ly/2i8QDk5
Request for an in-depth table of contents for
this report _at_ http//bit.ly/2fMwLSO
6Stay In Touch Website www.gminsights.com Soci
al Media